MGRC Partners with Ant Group Digital Technologies: Pioneering Blockchain Traceability in Biopharmaceutical Production

Blending Innovative Biopharmaceutical Production with Advanced Traceability

PETALING JAYA, 8 NOVEMBER 2023 – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics and biopharmaceutical specialist, is elated to announce that their wholly-owned subsidiary MGRC Biopharma Sdn. Bhd. has entered into a collaboration with AntChain Technology Pte Ltd, a subsidiary of Ant Group Digital Technologies, to integrate MGRC’s expertise in personalised and precision medicine with Ant Group Digital Technologies’ technological acumen, particularly in blockchain traceability.

Renowned for its delivery of services spanning genetics, genomics, biopharmaceuticals and immunotherapy such as cell gene therapy covering CAR-T cells and Natural Killer (NK) cells, MGRC Biopharma finds a harmonious alignment with Ant Group Digital Technologies’ innovative capabilities. Ant Group Digital Technologies’ unique traceability technologies, together with its technical expertise in data analytics and intelligent risk management, are set to become instrumental in preserving resource integrity within MGRC’s biopharmaceutical and cell lab products, stirring a continual desire for MGRC’s increased efforts towards sustainability.

The heart of this partnership revolves around MGRC Biopharma integrating Ant Group Digital Technologies’ AntChain TaaS traceability solution and is made possible through its strategic local partnerships in the healthcare sector. Beyond this integration, both companies are keen on exploring a spectrum of digital ventures that could amplify the efficacy and reach of MGRC’s offerings.

Azri Azerai, Executive Chairman of Malaysian Genomics, stated, "Our alliance with Ant Group Digital Technologies is emblematic of our unwavering commitment to innovation. By intertwining blockchain traceability within our production framework, we not only bolster product authenticity but also reinforce our promise of excellence to our stakeholders. This alliance is a testament to our aspiration of merging state-of-the-art technology with biopharmaceutical expertise."

Derrick Loi, General Manager of International Business, Ant Group Digital Technologies, said, "Collaborating with a distinguished entity like MGRC enriches our journey to help accelerate the digital transformation and digital collaboration across different industries. Together, we’re charting a course where innovative technologies and healthcare meld seamlessly, setting the stage for ground-breaking strides in the sector."

As they set their sights on the horizon, MGRC and Ant Group Digital Technologies remain resolute in their shared goal: to deliver unparalleled value to their stakeholders and spearhead innovations that redefine the confluence of technology and healthcare.

The Group has paid a courtesy visit to YB Tuan Ahmad Fahmi Bin Mohamed Fadzil, Minister of Communications and Digital Malaysia upon the collaboration signing ceremony and discussed further on how MGRC and Ant Group Digital Technologies are able to contribute to the digitalisation of the healthcare industry.

As of 7 November 2023, MGRC’s share price is at 0.47 sen, with a market capitalisation of RM65.2 million.